Skip to main content

Maternal and Neonatal Group B Streptococcus in Brazil: A Systematic Review Highlighting Epidemiological Gaps and Opportunities for Improved Prevention

In brief

Brazilian studies estimate group B strep carriage in 17% of pregnant women

A review of 49 studies found an estimated 17% maternal carriage rate, but results varied greatly across studies. Reported early-onset newborn infections ranged from 0.01 to 0.45 per 1,000 births, underscoring how limited surveillance leaves Brazil's disease burden uncertain and prevention needs difficult to assess.

Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Q1)
Published
19 November 2026
Study design
Systematic review of cohort studies
Evidence level
Level 2, Moderate (CEBM 2a)
Authors
Tatiana Castro Abreu Pinto, Laura Maria Andrade Oliveira, Natalia Silva Costa, André Rio-Tinto, Ana Clarisse Merces, Leandro Correa Simoes, et al.
PMID
43057612
DOI
10.1016/j.ijid.2026.109265

Why clinicians should know about it

  • Picked for Epidemiology (top studies of the week, 22 November 2026): Maternal carriage, neonatal disease burden, resistance, and surveillance gaps

Abstract

Group B Streptococcus (GBS) is a major cause of maternal and neonatal morbidity and mortality worldwide. In Brazil, national data on GBS epidemiology remain scarce. We aimed to provide a comprehensive synthesis of maternal carriage, neonatal disease, serotype distribution, and antimicrobial resistance. We did a systematic review and meta-analysis (PROSPERO CRD42023427476) following PRISMA 2020. PubMed/MEDLINE, EMBASE, Web of Science, Scopus, Cochrane Library, LILACS/SCIELO, and CINAHL were searched for studies published between January 1, 2000, and December 31, 2024. Meta-analyses were performed using StataNow/SE version 19.5 (StataCorp, College Station, TX, USA). Pooled prevalence estimates with 95% confidence intervals were calculated using the metaprop command and random-effects models, and between-study heterogeneity was assessed using the I² statistic. Forest plots were generated to illustrate pooled estimates. Forty-nine studies were included. Forty-three studies (n=64,658 samples) reported maternal GBS carriage, with a pooled prevalence of 17% (95% CI 14-20%; I2=98.55%). Eight studies, encompassing more than 32 million live births, assessed early-onset neonatal disease, and reported incidence estimates of 0.01-0.45 per 1,000 live births. Among 1,502 maternal and neonatal isolates, serotypes Ia, V, II and III predominated, in descending order of prevalence. Among 9,880 maternal isolates, pooled resistance to clindamycin and erythromycin was 12% and 14%, respectively; penicillin non-susceptibility was rare. GBS burden in Brazil is substantial but poorly defined. Strengthening laboratory diagnosis of invasive neonatal GBS disease, implementing accessible capsular serotyping methods, and expanding geographically representative surveillance are priorities to improve disease burden estimates and inform prevention policies, including future maternal GBS vaccine implementation.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.